General Drug Use-results Survey of Rituxan Intravenous infusion - Refractory Pemphigus Vulgaris and Pemphigus Foliaceus
Not Applicable
Recruiting
- Conditions
- pemphigus vulgaris and pemphigus foliaceus
- Registration Number
- JPRN-jRCT2031220115
- Lead Sponsor
- Ando Takashi
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 125
Inclusion Criteria
Patients with refractory pemphigus vulgaris and pemphigus foliaceus who have received Rituxan intravenous infusion.
Exclusion Criteria
none
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Incidence of adverse events and adverse drug reactions.<br>PDAI activity score, Clinical global impression-improvement, patient global impression-improvement.
- Secondary Outcome Measures
Name Time Method